Amended Live Biotherapeutic-study on subthreshold depression
Released
Released
Announcement PDF
Live Biotherapeutics — A new
intervention for sub-threshold depression
Presented by:
Blair Vega Norfolk, CEO, Biome Australia Ltd
Practitioner-only probiotics
ACTIVATEDPROBIOTICS.COM.AU
Microbiota-Gut-Brain
Psychology
2
The next generation of live biotherapeutic products – Precision
Probiotics
The range includes clinically-proven probiotics for:
Allergic asthma
Mineral absorption
Mood and sleep
Bone-density health
Condition-specific products with targeted strains
Practitioner-only probiotics
PAGE
Activated Probiotics
Supported by human clinical trials
Practitioner-only distribution
Ongoing clinical development of products in market
Clinically trialled
products
Condition
specific
Gluten free
Shelf-stable live
bacteria
Dairy free
One-a-day
formulation
ACTIVATEDPROBIOTICS.COM.AU
Practitioner-led clinical education and training
PG.2
3.4M
15%
Australians aged 16-85
experience a mental illness in
any year
Australians saw a health
professional for their mental
health in 2020-2021
of Australians felt lonely in the
previous four weeks
61%
45%
10%
of Australians used at least one
strategy to manage their mental
health
of the population will experience a
mental illness in their lifetime
of Australians are on an
antidepressant, with 38%
experiencing side effects
https://www.abs.gov.au/articles/first-insights-national-study-mental-health-and-wellbeing-2020-21
Commercial in confidence
3
PAGE
Practitioner-only probiotics
1 in 5
ACTIVATEDPROBIOTICS.COM.AU
The mental health landscape in Australia
PG.3
Angela Marotta,1,2,* Eleonora Sarno,3,† Antonio Del Casale,4,† Marco Pane,5 Luca
Mogna,5 Angela Amoruso,5 Giovanna E. Felis,3 and Mirta Fiorio1,*
1 Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
2 Neurology Unit, Neuroscience Department, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
3 Department of Biotechnology, University of Verona, Verona, Italy
4 Open Innovation Department, Microbion SRL, Verona, Italy
5 BIOLAB RESEARCH SRL, Novara, Italy
Commercial in confidence
PAGE 4
ACTIVATEDPROBIOTICS.COM.AU
Effects of Probiotics on Cognitive
Reactivity, Mood, and Sleep Quality
Practitioner-only probiotics
ORIGINAL RESEARCH
Published 2019 Mar 27.
doi: 10.3389/fpsyt.2019.00164
PG.4
The primary aim of the trial is to assess the efficacy of Biome
Lift™ compared to a placebo in reducing the severity of
symptoms in patients aged 18-65 with sub-threshold
depression.
The trial will be conducted at La Trobe University where 48
participants will be recruited and dosed once per day with
placebo or active over a 3-month period.
PAGE 5
Practitioner-only probiotics
Biome Lift™ Clinical Trial
●
●
●
●
Take one probiotic or placebo daily, for 3 months
Complete one brief weekly questionnaire about their
mood
Complete a set of questionnaires at 3 time points
(before, during and after the probiotic or placebo)
Collect saliva, faecal and have blood samples
collected for analysis at 3 time points (before, during
and after the probiotic or placebo)
Commercial in confidence
ACTIVATEDPROBIOTICS.COM.AU
Participants will:
PG.5
PAGE 6
Biome Lift™ Clinical Trial
The secondary outcome measures will be:
1. Subjective and clinical assessment of depression, anxiety, mood and QoL, using the following validated questionnaires:
Structured Clinical Interview for DSM-5 (SCID 5; clinically administered; depression symptoms) [pre and post only]
Hospital Anxiety and Depression Scale (HADS; self-report; anxiety and depression) [4 timepoints at pre, mid, post and
follow-up]
Beck Depression Inventory (BDI-II; self-report; depression) [4 timepoints at pre, mid, post and follow-up]
Depression, Anxiety and Stress Scale (DASS-21; self-report; depression, anxiety and stress severity ratings) [4 timepoints
at pre, mid, post and follow-up]
Assessment of Quality of Life (ADoL-6D; self-report; health-related quality of life) [4 timepoints at pre, mid, post and
follow-up]
2. A range of inflammatory and metabolic biomarkers assessed via blood samples including: insulin, hs-CRP, plasma GSH
(glucose, TNF-a, IL-6, IL-10 – these will be analysed after the study competition with additional funding. [3 timepoints at pre, mid
and post]
3. Gut microbiota composition changes assessed via fecal samples testing for microbiota genome and functional
predictions of gut microbiota. [3 timepoints at pre, mid and post]
4. Salivary cortisol as a biomarker of stress assessed via saliva sample collection. [3 timepoints at pre, mid and post]
5. Subjective assessment of gastrointestinal health using the following validated questionnaire:
Irritable bowel syndrome-severity scoring system (IBS-SSS; self-report; gut symptom severity) [4 timepoints at pre, mid,
post and follow-up]
Commercial in confidence
ACTIVATEDPROBIOTICS.COM.AU
Subjective assessment of depression using the following validated questionnaire weekly:
Patient Health Questionnaire (PH9; self-report, brief specifically measures depression and has been shown to be
responsive to intervention) [weekly]
Practitioner-only probiotics
The primary outcome measure will be:
PG.6
7
PAGE
Practitioner-only probiotics
Biome Lift™
Clinically trialled product
ACTIVATEDPROBIOTICS.COM.AU
TGA APPROVED INDICATIONS
Commercial in confidence
PG.7
PAGE 8
The LBP Opportunity - Adjunct to Medications
Practitioner-only probiotics
Given the high level of clinical evidence and low risk profile associated with live biotherapeutic products (LBPs),
Activated Probiotics has developed a program to support co-prescribing alongside medications by general practitioners
and pharmacists in Australia.
When a medication is prescribed for a particular health condition that has been researched within the LBP space, a
companion recommendation can be made to help improve the patient’s treatment and health outcomes, if the product
is commercially available.
Activated Probiotics refers to this market as “the adjunct medication market”
Medication volume July 2020-June 2021
10M
Prescriptions
per year
48M
Prescriptions
per year
Activated Probiotics Product with adjunct opportunities within
the ATC category
Biome Advanced
Probiotic
To help restore the balance of beneficial gut
bacteria after antibiotic use
Biome Lift
Probiotic
To support healthy mood balance and enhance
sleep quality
Commercial in confidence
ACTIVATEDPROBIOTICS.COM.AU
ATC medication category
PG.8
PAGE 9
Practitioner-only probiotics
Clinical Detailing and
Education Support
Unique Education and Service Commercialisation
Model
Education-focused promotion
• Practitioner education consultants undertake
education-driven engagement in key health practitioner
channels
• Training and education aims to provide product and
scientific knowledge to healthcare practitioners and
develop stronger understanding of LBPs
Commercial in confidence
ACTIVATEDPROBIOTICS.COM.AU
• An alternative model to traditional pharmaceutical sales
and education
PG.9
Practitioner-only probiotics
PAGE
10
Regulatory
Environment
Therapeutic Goods Administration (TGA)
All medicines supplied in Australia must be
included in the Australian Register of
Therapeutic Goods (ARTG).
●
●
●
ACTIVATEDPROBIOTICS.COM.AU
Medicines will be either:
AUST L
AUST L(A)
AUST R
Medical Devices are categorised differently
Commercial in confidence
PG.10
ACTIVATEDPROBIOTICS.COM.AU
Practitioner-only probiotics
PAGE
11
Regulatory
Environment
https://www.tga.gov.au/how-we-regulate-medicines
Commercial in confidence
PG.11
ACTIVATEDPROBIOTICS.COM.AU
Practitioner-only probiotics
Thank You
IPC2022
Share your feedback
Discover